Lobe Sciences Ltd.
LOBEF
$0.08
-$0.01-6.21%
OTC PK
| 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 919.10K | 334.70K | 1.10M | 548.20K | 434.20K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.75M | 1.04M | 1.35M | 748.40K | 443.20K |
| Operating Income | -1.75M | -1.04M | -1.35M | -748.40K | -443.20K |
| Income Before Tax | -1.75M | -935.40K | -1.62M | -807.10K | -491.30K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.75M | -935.40K | -1.62M | -807.10K | -491.30K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 443.50K | 279.10K | 206.70K | 107.00K | -- |
| Net Income | -1.31M | -656.20K | -1.41M | -700.10K | -491.30K |
| EBIT | -1.75M | -1.04M | -1.35M | -748.40K | -443.20K |
| EBITDA | -- | -- | -1.33M | -733.30K | -428.40K |
| EPS Basic | 0.00 | 0.00 | -0.72 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | -0.46 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | -0.72 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | -0.46 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 269.49M | 267.20M | 1.97M | 192.76M | 186.37M |
| Average Diluted Shares Outstanding | 269.49M | 267.20M | 1.97M | 192.76M | 186.37M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |